Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126584042 | 12658404 | 2 | F | 201604 | 20160817 | 20160817 | 20160830 | EXP | GB-ACCORD-041761 | ACCORD | 41.00 | YR | A | F | Y | 0.00000 | 20160830 | CN | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126584042 | 12658404 | 1 | PS | DOCETAXEL. | DOCETAXEL | 1 | U | 201195 | |||||||||||
126584042 | 12658404 | 2 | SS | PALONOSETRON/PALONOSETRON HYDROCHLORIDE | PALONOSETRON HYDROCHLORIDE | 1 | U | 1161104 | |||||||||||
126584042 | 12658404 | 3 | SS | EPIRUBICIN | EPIRUBICIN | 1 | U | 2147483647 | |||||||||||
126584042 | 12658404 | 4 | SS | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | U | 11811 | |||||||||||
126584042 | 12658404 | 5 | SS | NEULASTA | PEGFILGRASTIM | 1 | U | 0 | |||||||||||
126584042 | 12658404 | 6 | SS | TAXOTERE | DOCETAXEL | 1 | U | 0 | |||||||||||
126584042 | 12658404 | 7 | SS | APREPITANT. | APREPITANT | 1 | Oral | DOSAGE FORM: UNSPECIFIED, DOSAGE - 168 (UNITS UNSPECIFIED) | U | 0 | |||||||||
126584042 | 12658404 | 8 | SS | CYCLOPHOSPHAMIDE/CYCLOPHOSPHAMIDE MONOHYDRATE | CYCLOPHOSPHAMIDE | 1 | U | 0 | |||||||||||
126584042 | 12658404 | 9 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | DOSAGE FORM: UNSPECIFIED, DOSAGE: 245 (UNITS UNSPECIFIED) | U | 0 | |||||||||
126584042 | 12658404 | 10 | SS | DOMPERIDONE | DOMPERIDONE | 1 | U | 0 | |||||||||||
126584042 | 12658404 | 11 | SS | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126584042 | 12658404 | 1 | Product used for unknown indication |
126584042 | 12658404 | 2 | Product used for unknown indication |
126584042 | 12658404 | 3 | Product used for unknown indication |
126584042 | 12658404 | 4 | Product used for unknown indication |
126584042 | 12658404 | 5 | Product used for unknown indication |
126584042 | 12658404 | 6 | Product used for unknown indication |
126584042 | 12658404 | 7 | Product used for unknown indication |
126584042 | 12658404 | 8 | Product used for unknown indication |
126584042 | 12658404 | 9 | Product used for unknown indication |
126584042 | 12658404 | 10 | Product used for unknown indication |
126584042 | 12658404 | 11 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126584042 | 12658404 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126584042 | 12658404 | Alopecia | |
126584042 | 12658404 | Ear discomfort | |
126584042 | 12658404 | Epistaxis | |
126584042 | 12658404 | Fatigue | |
126584042 | 12658404 | Haemoglobin decreased | |
126584042 | 12658404 | Infusion site erythema | |
126584042 | 12658404 | Infusion site pruritus | |
126584042 | 12658404 | Infusion site vesicles | |
126584042 | 12658404 | Joint swelling | |
126584042 | 12658404 | Limb discomfort | |
126584042 | 12658404 | Neuropathy peripheral | |
126584042 | 12658404 | Pain in extremity | |
126584042 | 12658404 | Peripheral swelling | |
126584042 | 12658404 | Pyrexia | |
126584042 | 12658404 | Rosacea | |
126584042 | 12658404 | Thrombosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126584042 | 12658404 | 1 | 20160602 | 0 | ||
126584042 | 12658404 | 5 | 20160603 | 0 | ||
126584042 | 12658404 | 6 | 20160602 | 0 |